Key Takeaways

  • Compounded GLP-1s rose from zero in 2018 to 86% of compounded weight-loss prescriptions in Nebraska's monitoring data by 2025.
  • They are commonly combined with vitamin B12 or levocarnitine — combinations that have not been tested for safety.
  • Because nearly all of it is cash-pay, the market is largely invisible in insurance data, the researchers warn.

The copycat versions quietly took over

Compounded GLP-1 drugs — pharmacy-made versions of medications like semaglutide and tirzepatide — did not exist in Nebraska's prescription-monitoring records in 2018. By 2025, they accounted for 86% of all compounded weight-loss prescriptions in the state's database, according to a study published this week in JAMA by researchers at the University of Utah and partner institutions.

"Compounded GLP-1s have grown into a large market, but because nearly all of it is cash-pay, it is essentially invisible to the insurance claims data researchers typically use," said lead author Joey Mattingly, an associate professor of pharmacotherapy at the University of Utah. "We had no systematic picture of what is actually being dispensed to patients."

What is being added to the syringe

The study found the compounded products are commonly co-formulated with additives such as vitamin B12 and levocarnitine, a molecule involved in metabolism. The additives are often marketed as preventing GLP-1 side effects, the researchers say — but there is little evidence they work, and the combinations have never been tested for safety together.

"Compounded products with additives are not the same as the FDA-approved drugs, and the composition and quality of what a patient is injecting is often unverifiable," Mattingly said. "The risks are largely unknown." Some added substances are not regulated by the FDA at all, the study notes, and the authors call for better tracking and stronger safety standards. They also urge clinicians to ask patients directly about compounded GLP-1 use, since cash purchases may never appear in a patient's pharmacy history.

Health note: Compounded GLP-1 products are not FDA-approved versions of brand-name drugs, and their contents can vary. Anyone using or considering one should discuss it openly with their doctor or pharmacist — especially before combining products.

The Twikup Take

The brand-name drugs went through years of trials; the compounded versions riding their popularity largely have not — and the additives mixed into them have not been tested together for safety. A cheaper injection is not automatically the same medicine.

Image: Illustrative image.

Sources